Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Am Coll Cardiol 2012;60:1581–98.10.1016/j.jacc.2012.08.001Search in Google Scholar PubMed
2. Apple FS, Collinson PO, IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54–61.10.1373/clinchem.2011.165795Search in Google Scholar PubMed
3. Krintus M, Kozinski M, Boudry P, Capell NE, Köller U, Lackner K, et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin Chem Lab Med 2014;52:1657–65.10.1515/cclm-2014-0107Search in Google Scholar PubMed
4. STAT High Sensitive Troponin-I assay Technical Sheet Abbott Architect System Ref. 3P25 B3P252 G4-5979/R04 November 2013.Search in Google Scholar
5. Sadler WA. Imprecision profiling. Clin Biochem Rev 2008;29 (Suppl 1):S33–6.Search in Google Scholar
6. Zhang S, Zeng J, Zhang C, Li Y, Zhao H, Cheng F, et al. Commutability of possible external quality assessment materials for cardiac troponin measurement. PLoS One 2014;9:e102046.10.1371/journal.pone.0102046Search in Google Scholar PubMed PubMed Central
7. Candás-Estébanez B, Cano-Corres R, Dot-Bach D, Valero-Politi J. Lack of commutability between a quality control material and plasma samples in a troponin I measurement system. Clin Chem Lab Med 2012;50:2237–8.10.1515/cclm-2011-0738Search in Google Scholar PubMed
8. Clerico A, Ripoli A, Masotti S, Prontera C, Storti S, Fortunato A, et al. Pilot study on harmonization of cardiac troponin I immunoassays using patients and quality control plasma samples. On behalf of the Italian Section of the European Ligand Assay Society (ELAS) and of the Study Group on Cardiovascular Biomarkers of the Società Italiana di Biochimica Clinica (SIBioC). Clin Chim Acta 2016;456:42–8.10.1016/j.cca.2016.02.017Search in Google Scholar PubMed
9. Wu AH, Christenson RH, Greene DN, Jaffe AS, Kavsak PA, Ordonez-Llanos J, et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the academy of the american association for clinical chemistry and the task force on clinical applications of cardiac bio-markers of the international federation of clinical chemistry and laboratory medicine. Clin Chem 2018;64:645–55.10.1373/clinchem.2017.277186Search in Google Scholar PubMed
10. Simpson AJ, Potter JM, Koerbin G, Oakman C, Cullen L, Wilkes GJ, et al. Use of observed within-person variation of cardiac troponin in emergency department patients for determination of biological variation and percentage and absolute reference change values. Clin Chem 2014;60:848–54.10.1373/clinchem.2013.219410Search in Google Scholar PubMed
11. Kavsak PA, Don-Wauchope AC, Hill SA, Worster A. Acceptable analytical variation may exceed high-sensitivity cardiac Troponin I cutoffs in early rule-out and rule-In acute myocardial infarction algorithms. Clin Chem 2016;62:887–9.10.1373/clinchem.2016.255448Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
